Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...

New research shows diabetes drugs may significantly reduce the risk of dementia, Alzheimer's, and Parkinson’s disease.

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a new study.

According to a new study, certain diabetes medications may significantly reduce this risk. These drugs, called gliflozins or ...

If you've recently received a diagnosis of type 2 diabetes, understanding your treatment options is an important first step.

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

New research published in New England Journal of Medicine and presented at this year's Annual Meeting of the European ...

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study ...

a medication for diabetes, have shown a reduction in risk not only for Alzheimer's disease but also for other types of neurodegenerative diseases such as vascular dementia and Parkinson's disease ...

Type 2 diabetes is characterized by the body's inability to use insulin effectively. Insulin is a hormone that helps regulate metabolism properly. The condition is the most common type of ...